|
1
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2013. CA Cancer J Clin. 63:11–30. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Uhland K: Matriptase and its putative role
in cancer. Cell Mol Life Sci. 63:2968–2978. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Nakamura K, Hongo A, Kodama J, Abarzua F,
Nasu Y, Kumon H and Hiramatsu Y: Expression of matriptase and
clinical outcome of human endometrial cancer. Anticancer Res.
29:1685–1690. 2009.PubMed/NCBI
|
|
5
|
Tanimoto H, Underwood LJ, Wang Y,
Shigemasa K, Parmley TH and O'Brien TJ: Ovarian tumor cells express
a transmembrane serine protease: A potential candidate for early
diagnosis and therapeutic intervention. Tumour Biol. 22:104–114.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Saleem M, Adhami VM, Zhong W, Longley BJ,
Lin CY, Dickson RB, Reagan-Shaw S, Jarrard DF and Mukhtar H: A
novel biomarker for staging human prostate adenocarcinoma:
Overexpression of matriptase with concomitant loss of its
inhibitor, hepatocyte growth factor activator inhibitor-1. Cancer
Epidemiol Biomarkers Prev. 15:217–227. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Vogel LK, Saebø M, Skjelbred CF, Abell K,
Pedersen ED, Vogel U and Kure EH: The ratio of Matriptase/HAI-1
mRNA is higher in colorectal cancer adenomas and carcinomas than
corresponding tissue from control individuals. BMC Cancer.
6:1762006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zeng L, Cao J and Zhang X: Expression of
serine protease SNC19/matriptase and its inhibitor hepatocyte
growth factor activator inhibitor type 1 in normal and malignant
tissues of gastrointestinal tract. World J Gastroenterol.
11:6202–6207. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Jin JS, Chen A, Hsieh DS, Yao CW, Cheng MF
and Lin YF: Expression of serine protease matriptase in renal cell
carcinoma: Correlation of tissue microarray immunohistochemical
expression analysis results with clinicopathological parameters.
Int J Surg Pathol. 14:65–72. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Santin AD, Cane' S, Bellone S, Bignotti E,
Palmieri M, De Las Casas LE, Anfossi S, Roman JJ, O'Brien T and
Pecorelli S: The novel serine protease tumor-associated
differentially expressed gene-15 (matriptase/MT-SP1) is highly
overexpressed in cervical carcinoma. Cancer. 98:1898–1904. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Nakamura K, Hongo A, Kodama J, Abarzua F,
Nasu Y, Kumon H and Hiramatsu Y: Expression of matriptase and
clinical outcome of human endometrial cancer. Anticancer Res.
29:1685–1690. 2009.PubMed/NCBI
|
|
12
|
List K, Bugge TH and Szabo R: Matriptase:
Potent proteolysis on the cell surface. Mol Med. 12:1–7. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Bristow RE, Chang J, Ziogas A, Campos B,
Chavez LR and Anton-Culver H: Impact of National Cancer Institute
Comprehensive Cancer Centers on ovarian cancer treatment and
survival. J Am Coll Surg. 220:940–950. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zeppernick F and Meinhold-Heerlein L: The
new FIGO staging system for ovarian, fallopian tube, and primary
peritoneal cancer. Arch Gynecol Obstet. 290:839–842. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Chang C and Werb Z: The many faces of
metalloproteases: Cell growth, invasion, angiogenesis and
metastasis. Trends Cell Biol. 11:S37–S43. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Del Rosso M, Fibbi G, Pucci M, D'Alessio
S, Del Rosso A, Magnelli L and Chiarugi V: Multiple pathways of
cell invasion are regulated by multiple families of serine
proteases. Clin Exp Metastasis. 19:193–207. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lisk K, Bugge TH and Szabo R: Matriptase:
Potent proteolysis on the cell surface. Mol Med. 12:1–7. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Takeuchi T, Harris JL, Huang W, Yan KW,
Coughlin SR and Craik CS: Cellular localization of membrane-type
serine protease1 and identification of protease-activated
receptor-2 and single-chain urokinase-type plasminogen activator as
substrates. J Biol Chem. 275:26333–26342. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lee SL, Dickson RB and Lin CY: Activation
of hepatocyte growth factor and urokinase/plasminogen activator by
matriptase, an epithelial membrane serine protease. J Biol Chem.
275:36720–36725. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Oberst MD, Johnson MD, Dickson RB, Lin CY,
Singh B, Stewart M, Williams A, al-Nafussi A, Smyth JF, Gabra H and
Sellar GC: Expression of the serine protease matriptase and its
inhibitor HAI-1 in epithelial ovarian cancer: Correlation with
clinical outcome and tumor clinicopathological parameters. Clin
Cancer Res. 8:1101–1107. 2002.PubMed/NCBI
|
